APA (7th ed.) Citation

L, T., L, B., MR, L., CF, T., P, A., R, E., . . . K, K. (2026). Establishment of a humanized patient-derived xenograft mouse model of high-grade serous ovarian cancer for preclinical evaluation of combination immunotherapy. Molecular oncology. https://doi.org/10.1002/1878-0261.70231

Chicago Style (17th ed.) Citation

L, Tandaric, et al. "Establishment of a Humanized Patient-derived Xenograft Mouse Model of High-grade Serous Ovarian Cancer for Preclinical Evaluation of Combination Immunotherapy." Molecular Oncology 2026. https://doi.org/10.1002/1878-0261.70231.

MLA (9th ed.) Citation

L, Tandaric, et al. "Establishment of a Humanized Patient-derived Xenograft Mouse Model of High-grade Serous Ovarian Cancer for Preclinical Evaluation of Combination Immunotherapy." Molecular Oncology, 2026, https://doi.org/10.1002/1878-0261.70231.